Recurrent Rectal Carcinoma (DBCOND0047446)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT02465060	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	ABSK-091 Adavosertib Afatinib Binimetinib Capivasertib Copanlisib Crizotinib Dabrafenib Dasatinib Defactinib Erdafitinib GSK-2636771 Ipatasertib Larotrectinib Methane Nivolumab Osimertinib Palbociclib Pertuzumab Relatlimab Sapanisertib Sulfate ion Sunitinib Taselisib Trametinib Trastuzumab Trastuzumab emtansine Tyrosine Ulixertinib Vismodegib	screening	2	active_not_recruiting
NCT01254617	Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer	Cetuximab Lenalidomide	treatment	1	completed
NCT01131234	Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors	Cediranib RG-4733	treatment	1	completed
NCT00745134	Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer	Capecitabine	treatment	2	terminated
NCT01198535	Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer	Cetuximab RG-4733	treatment	1	terminated
NCT01802320	Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery	No drug interventions	treatment	2	completed
NCT03365882	S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery	Camptothecin Cetuximab Irinotecan Pertuzumab Trastuzumab	treatment	2	active_not_recruiting
NCT01383343	Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer	Bevacizumab Calcium Camptothecin Fluorouracil Irinotecan Leucovorin Levoleucovorin Sorafenib	treatment	1	completed
NCT04213794	Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients	Chloride ion Cisplatin Daunorubicin Doxorubicin Platinum Thiosulfuric acid	treatment	0	active_not_recruiting
NCT00068692	Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer	Camptothecin Fluorouracil Irinotecan Leucovorin Oxaliplatin Platinum	treatment	3	completed
NCT03297710	TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery	TAS-102 Tipiracil Trifluridine	treatment	1	completed
NCT02393755	Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer	Capecitabine Nintedanib Tyrosine	treatment	1 / 2	completed
NCT01729923	A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer	Capecitabine Celecoxib	treatment	2	terminated